COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn PVP-IPVP-I REGNREGN LY-CoVLY RemdesivirRMD
HCQ meta analysis
9/18 Late treatment study
Axfors et al., medRxiv, doi:10.1101/2020.09.16.20194571 (Preprint) (meta analysis - not included in study count)
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19: an international collaborative meta-analysis of randomized trials
Source   PDF   Share   Tweet
Meta analysis assigning 87% weight to the RECOVERY trial, producing the same result. The RECOVERY trial used excessively high non-patient-customized dosage in very sick late stage patients and the result is not generalizable to typical dosage or earlier treatment.

Axfors et al., 9/18/2020, preprint, 97 authors.
Details of all 230 studies    Meta analysis
Please submit corrections, updates, or comments.
Submit